MedTrace Logo

Promoting Flu Vaccination Through a Mobile Wellness Program

NCT02908893 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 77983

Last updated 2016-10-21

No results posted yet for this study

Summary

The investigators design a 6-week messaging campaign aimed at promoting flu vaccination among fully insured members of a national payer that participate in a wellness program offered by the insurer through a mobile app. Outcomes measured will include uptake in flu vaccination rate as measured by the insurer and engagement with the campaign through the app.

The goal of the research is to assess the effectiveness of pervasive computing messaging in promoting preventative care treatments such as flu shots. An additional goal is that of quantifying the importance of emphasizing incentives to increase efficacy of the messages.

Conditions

  • Not Condition-specific

Interventions

BEHAVIORAL

In-app and push notification mobile messages

Short messages (100-250 characters) are to be delivered to a mobile app both by push notification (i.e., appearing on the phone dashboard like a text message if the user has allowed notifications from the app) and in-app messages (visible in the news feed of the wellness program app when the app is opened). Messages contain a short title (30 characters) and 2-3 lines of text in the body (30 characters each).

Sponsors & Collaborators

  • Defense Advanced Research Projects Agency

    collaborator FED

  • Army Research Office (ARO)

    collaborator UNKNOWN

  • Evidation Health

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2016-12-31
Completion
2017-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02908893 on ClinicalTrials.gov